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Abstract
Based on previous studies, a minimal set of genetic
alterations that is required to convert normal human
fibroblasts into cancer cells has been defined. Essen-
tial roles for telomere maintenance and alterations in
phosphatase 2A activity were inferred from experi-
ments in which tumorigenicity was tested by injecting
cells under the skin of immunodeficient mice. How-
ever, in the present experiments, the combination of
SV40 large T antigen and activated Ras, without hTERT
or SV40 small t antigen, was sufficient to convert nine
different primary human fibroblast cell strains to a fully
malignant state. The malignant behavior of the cells
was demonstrated by growth of the cells into invasive
tumors when the cells were injected beneath the
kidney capsule of immunodeficient mice. Lung metas-
tases and circulating tumor cells were also detected.
These tumors were not immortal; cells entered crisis,
from which they could be rescued by expression of
hTERT. However, the same cell populations were not
tumorigenic when they were injected under the skin.
In this site, tumorigenicity required the expression of
hTERT and SV40 small t antigen as well as SV40 large
T antigen and Ras. The cellular pathways targeted by
SV40 large T antigen (p53 and pRb) and those targeted
by activated Ras represent a minimal set of genetic
alterations required for the conversion of normal
human fibroblasts into cancer cells.
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Introduction
To define genetic alterations needed to convert a normal
human cell into a cancer cell, it is necessary to have a
reliable method for assessing the tumorigenic potential of
genetically modified cells. Obviously, in the case of human
cells, tumorigenic potential must be tested by growth of
the cells as a xenograft in immunodeficient mice, rather
than by growth in a syngeneic host as is possible for
experimental animals. Beginning with the introduction of the
nude (athymic) mouse into cancer research, it became routine
to assay tumorigenicity by injection of cells subcutaneously or
intramuscularly. For human cells, the definition of an oncogene
became firmly linked to the assay of subcutaneous growth in
immunodeficient animals.
Using subcutaneous growth to define the genes needed to
make a cancer cell, it was found that the combination of four
genetic elements—SV40 large T antigen (LT), SV40 small
t antigen (ST), oncogenic Ras, and human telomerase reverse
transcriptase subunit (hTERT)—represented a minimal set of
genes required for the neoplastic transformation of primary
human fibroblasts and several other human cell types [1–3].
These experiments yield the conclusion that the cellular path-
ways or processes that are perturbed by the introduction of
these genes define a minimal set of cellular/molecular alter-
ations needed to convert normal human fibroblasts into cancer
cells. These alterations involve the maintenance of telomeres
by telomerase, inactivation of the retinoblastoma (pRB) and
p53 tumor-suppressor pathways (by SV40 LT), acquisition of a
constitutive mitogenic signal provided by oncogenic Ras, and
perturbation of protein phosphatase 2A by SV40 ST [2,3].
Although injection of cells beneath the skin of immuno-
deficient mice has been the predominant method of assessing
the tumorigenicity of human cells, there is no reason to assume
that this site is optimal for tumor formation by implanted cells.
Other sites in the body may provide a better microenvironment
for tumor growth. In particular, the kidney has long been
known to support the growth of primary human tumors [4].
Following the success of the growth of solid tumor fragments in
the kidney, the technique was adapted for cultured cells by
embedding them in a fibrin clot before they were inserted under
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the kidney capsule [5]. More recently, the subrenal capsule
space has been used for tissue recombination and recon-
struction, as applied to breast and prostate tissues [6,7].
However, even before these techniques were introduced, it
had already been demonstrated that cancer cells will grow
into tumors when injected as cell suspensions beneath the
capsule of the kidney [8,9]. Studies in this laboratory on
adrenocortical cells showed that injection of cells under the
capsule of the kidney was ideal for cell survival, permit-
ting functional vascularized tissue formation from normal
primary cells [10–12].
Using the subrenal capsule assay for assessing tumori-
genicity, we found that bovine and human adrenocortical
cells could form invasive and metastatic tumors with just two
of the four genes, SV40 LT and Ras [13]. It was necessary to
prove that the tumors were truly telomerase-negative and
lacked a telomere maintenance mechanism. Because bo-
vine cells have longer telomeres than human cells, tumors
that were formed from bovine cells were much larger than
those formed from human adrenocortical cells. This enabled
two experiments that were not feasible with the human
adrenocortical tumors; first, it was possible to flow sort cells
from the primary tumor and obtain sufficient cells for an
assay of telomerase activity, and, second, it was possible
to serially transplant the tumors to secondary, and some-
times tertiary, host animals. These experiments proved that
the cells truly lack a telomere maintenance mechanism, thus
eliminating telomerase as an essential component of the
cellular pathways and processes that are needed for the
tumorigenic conversion of this cell type.
However, when we used subcutaneous growth, rather than
growth in the subrenal capsule assay, as the test of tumori-
genicity in genetically modified bovine adrenocortical cells,
we found that hTERT was required together with SV40 LT
and Ras. This suggested, consistent with other observa-
tions [14], that hTERT has effects on cellular behavior that
are not linked to its effects on telomere maintenance. We
also found that subcutaneous growth of genetically modified
bovine adrenocortical cells did not require SV40 ST [13].
In the present experiments, we set out to clarify whether
these findings—that hTERT is needed for subcutaneous
tumor growth, but only two genes, SV40 LT and Ras, are
required for growth in the subrenal capsule assay—are true
for a more widely studied human cell type, the primary
human fibroblast. Prior studies have suggested that some
tumorigenic growth of genetically modified primary human
fibroblasts is possible without the introduction of telomerase
[15,16]. However, in these experiments, it was not shown
that the tumors truly lacked a telomere maintenance mech-
anism, or that the progressive loss of malignant properties
could be reversed by the introduction of hTERT, as we did
for adrenocortical cells [13]. To our knowledge, the ability of
genetically modified human fibroblasts to grow into tumors in
the subrenal capsule site has not previously been studied.
Here we compared the properties of primary human fibro-
blasts transduced with combinations of SV40 LT, ST, Ras,
and hTERT in subrenal capsule transplantation and conven-
tional subcutaneous injection.
Materials and Methods
Growth of Human Fibroblasts and Retroviral Transduction
Primary human fibroblasts were obtained as follows:
HCA2 (MJ-90) and HCA3 (BJ) were derived from the labora-
tory of Dr. Olivia Pereira-Smith (UTHSCSA, Houston, TX);
LF1 was a generous gift of Dr. John Sedivy (Brown Univer-
sity); CRL-2088 (CCD-1072sk), CRL-2091 (CCD-1070sk),
CRL-2094 (CCD-1077sk), CRL-2097 (CCD-1079sk),
CRL-2429 (CCD-1112sk), and CRL-2703 (CCD-1137sk)
were obtained from the American Type Culture Collection
(ATCC; Manassas, VA). The retroviruses used are of the
LX type [17] and have been described previously [13]. They
were constructed from pLEGFP-N1 (BD Biosciences Clon-
tech, Palo Alto, CA) by replacing the neo gene. SV40 large
T antigen (SV40 LT) was derived from an intronless cDNA.
A second version of this retrovirus was constructed using the
intron-containing early regionSV40DNA. The oncogenicRas
used is Ha-RasG12V. Retroviral plasmid pBabe-puro-hTERT
was generously donated by J. Campisi. The Phoenix cell line
(amphotropic) was used for the production of retroviral par-
ticles [18]. Phoenix cells were transfected with retroviral
plasmids by the calcium phosphate method. After 48 hours,
the supernatant medium was filtered through a 0.45-mm filter
and added to the target cells. Infection was allowed to
proceed for 48 hours. Because the retroviral constructs used
encode GFP, the rate of infection of the culture was moni-
tored by fluorescence microscopy.
Pure populations of transduced cells were prepared by
flow cytometry. More than 98% of the cells were fluorescent
after sorting. Sorted cells were expanded in culture for trans-
plantation or for biochemical studies. No drug selection was
used to introduce SV40 LT, ST, or Ras; but when pBabe-
hTERTwas used, cells were selected with 1 mg/ml puromycin.
Anchorage-independent growth was assayed by growth
in soft agarose [19]. Cells were plated in medium containing
0.4% lowmelting agarose over an underlay of 0.8% agarose.
After the agarose solidified, medium was added to the top
surface and replaced every 2 days.
Biochemical Characterization of Retrovirally
Transduced Cells
Western blot analysis was performed using standard
techniques. Antibodies used were: SV40 LT, mouse mono-
clonal PAb419 (EMD Biosciences, La Jolla, CA); and Ras,
rat monoclonal Y13-259 (EMD Biosciences). Telomerase
activity in detergent extracts of cells was assessed by the
telomerase repeat amplification protocol (TRAP) assay as
previously described [13]. Telomere restriction fragment
(TRF) analysis was performed as previously described [11]
with the exception that DNA fragments were separated by
pulse-field gel electrophoresis.
Transplantation of Cells in RAG2/,gc/ Mice
RAG2/,gc/mice were purchased from Taconic (Ger-
mantown, NY). Animals (both males and females) at an age
greater than 6weeks (f25 g bodyweight) were used in these
experiments. Procedures were approved by the institutional
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animal care committee and were carried out in accordance
with the NIH Guide for the Care and Use of Laboratory Ani-
mals. We transplanted 2  106 fibroblasts beneath the
kidney capsule as previously described for adrenocortical
cells [10–12]. Subcutaneous cell implantation was per-
formed using a 29-gauge needle. Potential leakage of cells
from the injection site was monitored by illumination with a
470-nm light source (Lightools Research, Encinitas, CA).
Animals were sacrificed at various times following trans-
plantation, as described in the Results section. Tumors were
visualized by fluorescence using a 470-nm light source in
conjunction with a low level of white light. This combination
allowed the direct visualization of the fluorescent tumor cells
together with the nonfluorescent organs.
Histologic and Immunohistochemical Analysis
The fixation, paraffin embedding, and histologic exami-
nation of tissue formed from transplanted cells were carried
out using standard techniques. SV40 LT was detected with
monoclonal antibody PAb416 (EMD Biosciences). Addi-
tionally, tissues were fixed using the AMeX method [20].
Thick (30–50 mm) sections were prepared from AMeX-fixed,
paraffin-embedded tissues and were used for immuno-
cytochemistry without antigen retrieval. Antibodies against
53BP1 and g-H2AX were obtained from Upstate Biotech-
nology (Lake Placid, NY). Bound antibodies were visualized
with biotinylated secondary antibodies and streptavidin–
fluorochrome conjugates (Vector Laboratories, Burlingame,
CA). Photography was performed using a Zeiss Axiovert
fluorescence microscope.
Results
Normal Human Fibroblasts Can Be Transformed to a Fully
Malignant State by SV40 LT and RasG12V
Nine different strains of normal human fibroblasts were
transduced with a combination of retroviruses encoding
SV40 LT and RasG12V. Fibroblasts were used at the earliest
passage level available for each strain. At the time of retro-
viral infection, all the cell populations used had a labeling
index of >90% (based on a 72-hour incubation in bromo-
deoxyuridine) and a remaining division potential before se-
nescence of at least 20 population doublings (PD) (data from
our own observations and data provided by the ATCC). One
of the retroviral constructs (RasG12V) also encoded GFP. Fol-
lowing selection by fluorescence-activated cell sorting, cells
were injected beneath the kidney capsule of immunodeficient
mice. Animals were sacrificed at 30 to 70 days following
cell transplantation. All SV40 LT/RasG12V–transduced fibro-
blast strains produced tumors that grew beneath the kid-
ney capsule (Figure 1; Table 1). Histologic sections of all
tumors showed invasion of the oncogene-expressing cells
into the kidney. Additionally, separate tumor masses within
the peritoneal cavity were detected in many animals, and in a
smaller number, metastases to the lungs were observed by
fluorescence and confirmed by histology (Figure 1). Circulat-
ing tumor cells were observed in the spleen by immuno-
cytochemistry. Although death was not a planned endpoint
of the experiments, some animals became moribund and
died because of the extent of tumor growth. Some fibroblast
strains, such as LF1, produced smaller tumors in the kidney
but even such small tumors invaded the kidney parenchyma
(Figure 1). By the criteria of extensive local growth, invasive-
ness, and metastatic potential, it is clear that the combination
of SV40 LT and RasG12V, without other genetic modifica-
tions, is sufficient to convert normal human fibroblasts into
cancer cells.
hTERT and SV40 ST Are Required for Tumorigenic Growth
in Cells Transplanted Subcutaneously
This conclusion is in disagreement with the consensus
that has emerged from experiments over the past 20 years
that the combination of SV40 LT and RasG12V is nontumori-
genic in normal human fibroblasts. These data include ex-
periments in which genes were introduced into the cells
by transfection as well as retroviral transduction [1,15]. How-
ever, all of the reported studies of tumorigenicity of these
cells in immunodeficient animals used subcutaneous or intra-
muscular injection to test malignant potential. A detailed
survey of the literature on the transformation of human fibro-
blasts by a variety of oncogenes does not reveal any in which
tumorigenicity was tested by insertion of the cells into the
kidney or other internal organs.
Considering the data from the literature together with the
results of the experiments reported here, we hypothesized
that hTERT and SV40 ST may be required for growth of
neoplastically transformed human fibroblasts under the skin
but not in internal organs. To test this, we constructed a
retrovirus that contains the SV40 early region (SV40 ER) in
its native form. Cells transduced with this retrovirus express
both SV40 LT and SV40 ST (Figure 2). To introduce hTERT,
we infected cells with pBabe-hTERT followed by puromycin
selection. Cells transduced with pBabe-hTERT showed
strong telomerase activity, whereas cells transduced with only
SV40ERandRasG12Vwere telomerase-negative (see below).
Four different populations of cells expressing combi-
nations of SV40 LT, SV40 ST, RasG12V, and hTERT were
injected under the dorsal skin of immunodeficient mice.
Only SV40 ER/Ras/hTERT cells formed tumors, whereas
SV40 LT/Ras, SV40 ER/Ras, and SV40 LT/Ras /hTERT did
not (Table 2). In the case of the latter three cell populations,
a small fluorescent bleb was visible under the skin imme-
diately following the injection. These blebs remained visible
for a few days but did not enlarge and eventually could no
longer be detected by fluorescence. In contrast, SV40 ER /
Ras/hTERT cells produced continuously enlarging tumors
that invaded into subcutaneous muscle and fat (Figure 2).
In view of the widespread use of anchorage-independent
growth as a surrogate assay for tumorigenic potential, we
also examined the ability of various transduced cell popu-
lations to form colonies by growth in soft agarose. Non-
transduced cells did not form colonies. In agreement with
observations on early-passage normal human fibroblasts
transduced with oncogenic Ras and/or hTERT [21], cells
transduced with SV40 LT and RasG12V formed colonies of
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various sizes; SV40 ER/Ras/hTERT cells formed larger
colonies (Figure 2). Although we did not investigate the
phenomenon in great detail, we noted that those SV40 LT/
Ras– transduced fibroblast strains that produced smaller
tumors in the kidney, notably LF1, also formed only very
small colonies by growth in soft agarose.
Tumors Formed from SV40 LT/Ras Cells Progressively
Lose Their Malignant Properties and Enter Crisis
We noted that tumors from animals sacrificed at later time
points were often not larger than those sacrificed at earlier
times, suggesting that tumors may stop growing or reach a
stage beyond which they grow very little. To test whether
tumors were losing the ability to continue to grow in immuno-
deficient mice, we performed the following serial transplan-
tation experiment. We excised 1-mm fragments from primary
tumors formed from SV40 LT/RasG12V–transduced HCA2
cells. Fragments were reimplanted beneath the kidney cap-
sule of secondary host animals and also beneath the skin.
Six of seven primary tumors were able to regrow to some
extent in the kidneys of secondary host animals, although
none of 10 was able to regrow under the skin. Secondary
tumors in the kidney were much slower-growing than the
primary tumors (Figure 3). No fragments from secondary
tumors could be regrown when implanted into the kidneys of
tertiary host animals; only scar tissue was observed at the
site of implantation. We conclude that tumors are not capable
of indefinite growth and reach a stage at which they either
Table 1. Malignant Transformation of Primary Human Fibroblasts by SV40 LT
and Ras.
Fibroblast Strain PDL Tumor
Incidence
Size at
45 days (cm)
HCA2 (MJ-90) 19 10/10 0.5–2.0
HCA3 (BJ) 8 6/6 0.5–1.5
CRL-2088 11 3/3 0.3–0.5
CRL-2091 18 3/3 0.5–1.5
CRL-2094 12 3/3 0.3–0.5
CRL-2097 11 3/3 0.3–0.8
CRL-2429 21 3/3 0.5–1.0
CRL-2703 8 3/3 1.5–2.0
LF1 20 3/3 0.2–0.3
The table lists the primary human fibroblast strains used, the population
doubling level (PDL) at which the cells were transduced with SV40 LT and
RasG12V, the incidence of tumors when cells were implanted in the kidney,
and the thickness of the tumors at the time of sacrifice of the animals.
Figure 1. Invasive and metastatic behavior of primary human fibroblasts expressing SV40 LT and RasG12V. (A) Two examples of tumors growing in the kidneys of
immunodeficient mice, in one case (right) showing additional separate tumor masses within the peritoneal cavity. Photographs were obtained using blue light
illumination for detection of GFP together with low-level white light for visualization of the host organs. (B) Lung metastases visualized by fluorescence. (C)
Hematoxylin and eosin–stained sections of two tumors showing invasion into the kidney; on the left is a section of a large tumor formed from CRL-2703 cells and
on the right is a section of a small tumor formed from LF1 cells. (D) Tumor cells in the lung (above) and spleen (below) revealed by immunocytochemistry using an
antibody against SV40 LT.
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stop growing or regress. This is also accompanied by loss of
malignant behavior. Primary tumors extensively invaded the
kidney and some formed metastases (Figure 1). Secondary
tumors showed much less invasion into the kidney (Figure 3)
and we found no metastases in these animals.
We hypothesized that the limited growth potential of SV40
LT/Ras tumors was caused by replicative senescence/crisis
of the tumor cells. Histologic observations of tumors formed
from SV40 LT/Ras cells showed a great heterogeneity of
cell size, many cells with enlarged and distorted nuclei, and
many cells with abnormal mitotic chromosomes (Figure 3).
Senescing human fibroblasts in culture accumulate DNA
damage foci that may be visualized as colocalization of
53BP1 and g-H2AX [22–24]. We observed large numbers
of these DNA damage foci in many sections of tumors from
SV40 LT/RasG12V–transduced fibroblasts (Figure 3). Tumors
were dissociated into isolated cells and the tumor cells were
separated from host mouse cells by flow sorting. When these
cells were placed in culture, they exhibited abnormal nuclear
shapes and micronucleation, anaphase bridges, and chroma-
tin strings between interphase nuclei (Figure 3). We conclude
that cells in tumors of SV40 LT/RasG12V–transduced cells
enter crisis. Such tumors often had large areas of necrotic cell
death, but we detected rather few cells with typical signs of
apoptosis (not shown).
Restoration of Tumorigenicity by Transduction with hTERT
The progressive loss of growth and malignant properties
of tumors formed from SV40 LT/RasG12V–transduced cells
appeared to result from crisis in the tumor cells. We hypoth-
esized that this was caused by lack of a telomere main-
tenance mechanism and that introduction of telomerase
into the cells would maintain telomeres and thereby restore
tumorigenicity. To test this, cells were isolated from primary
tumors formed from SV40 LT/RasG12V–transduced HCA2
cells and were purified by cell sorting. In culture, these cells
grew poorly and exhibited signs of crisis, as shown in
Figure 3. They were telomerase-negative both before trans-
plantation and after isolation from the tumor; thus, the com-
bination of SV40 LT and Ras does not confer detectable
telomerase activity (Figure 4).
Some of the telomerase-negative SV40 LT/RasG12V HCA2
cells were transduced with a retrovirus encoding hTERT.
Following drug selection, the cell growth rate increased,
until the cell population showed a proliferative rate at least
as great as that of primary cells. These cells had a high
level of telomerase activity (Figure 4). They were tumori-
genic when transplanted in the kidney. The TRF length
decreased progressively in HCA2 cells as they were trans-
duced with SV40 LT and RasG12V, then transplanted to form
a tumor, from which cells were isolated by flow sorting. It
then increased greatly when these cells were transduced
with hTERT and retransplanted to form a tumor (Figure 4).
Tumors formed from hTERT-transduced cells grew rapidly
and were invasive and metastatic (Figure 4). The malignant
properties of the tumors became even more prominent
when fragments of such tumors were serially transplanted
to subsequent hosts. Tumors could be retransplanted se-
quentially at least three times without any evidence of loss
of growth rate. Thus, hTERT rescues cells from crisis and
restores full tumorigenicity.
Discussion
The human diploid fibroblast has long been popular in
studies of neoplastic transformation because of its ease of
isolation from human subjects and its central role in under-
standing replicative senescence and crisis [25,26]. Attempts
to convert normal human fibroblasts into cancer cells by
direct genetic modification failed until Hahn et al. [1] reported
that four genes—SV40 LT, SV40 ST, Ras, and hTERT—
were required for this transformation. In particular, in that
study and in previous reports [15], the combination of SV40 LT
and Ras was nontumorigenic by the conventional criterion
of formation of tumors following subcutaneous injection
of the cells in immunodeficient mice. Further experiments
Table 2. Subcutaneous Tumor Formation by Genetically Modified Primary
Human Fibroblasts.
Tumor IncidenceGenetic Modifications
Subcutaneous Subrenal Capsule
SV40 LT, Ras 0/12 10/10
SV40 LT, SV40 ST, Ras 0/8 4/4
SV40 LT, Ras, hTERT 0/6 nd
SV40 LT, SV40 ST, Ras, hTERT 6/6 nd
The table shows tumor formation by HCA2 cells expressing the indicated
combinations of genes, when assayed by subcutaneous injection and
subrenal capsule transplantation.
nd, not determined.
Figure 2. Requirement for hTERT and SV40 ST for tumorigenicity when cells
are injected subcutaneously in immunodeficient mice. HCA2 human fibro-
blasts were transduced with retroviruses encoding either SV40 LT or SV40
ER, together with RasG12V and/or hTERT. (A) Western blot analysis show-
ing the expression of SV40 LT and SV40 ST in cells transduced with the
SV40 ER retrovirus. (1) Nontransduced HCA2 cells; (2) GM847 cells (SV40-
transformed cell line, used as positive control); (3) HCA2 cells transduced
with SV40 LT and RasG12V; (4) HCA2 cells transduced with SV40 ER and
RasG12V. (B) Two examples of subcutaneous tumors formed from HCA2
cells transduced with SV40 ER, RasG12V, and hTERT, showing invasion
into muscle (above) and fat (below). (C) Colony growth in soft agarose of
control and genetically modified HCA2 cells. con, control HCA2 cells; LT,
SV40 LT; ER, SV40 ER; R, Ras; hT, hTERT.
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in the same model—human fibroblasts and SV40 LT/SV40
ST/Ras/hTERT—have confirmed and amplified the conclu-
sion that these is a minimal set of genes required for neo-
plastic transformation [27–33].
However, we demonstrate here that this conclusion is not
valid when early-passage primary human fibroblasts are
transduced with SV40 LT and Ras and implanted beneath
the kidney capsule rather than under the skin of immuno-
deficient mice. Early-passage human fibroblasts transduced
with SV40 LT and RasG12V produced tumors that were
invasive and sometimes metastatic. Thus, using experi-
mental conditions that are as close to the in vivo situation as
possible—the use of early-passage cells and formation
of the tumor within an internal organ—both hTERT and
SV40 ST are eliminated from the minimal set of genes
required to convert human fibroblasts into cancer cells.
The present study used nine different strains of primary
human fibroblasts—all from normal donors and all used at
the earliest PD available. In agreement with previous data on
early-passage fibroblasts [21], we found that Ras had a
positive effect on growth; in particular, we found that Ras-
transduced cells exhibited anchorage-independent growth.
Later-passage cells show a radically different response to
Ras—in those cells, Ras causes senescence [34]. This has
Figure 3. Loss of malignant properties in SV40 LT/RasG12V tumors associated with occurrence of crisis. (A) Comparison of primary and secondary tumors.
SV40 LT/RasG12V– transduced HCA2 cells were injected under the kidney capsule and formed the lower tumor after 38 days. A 1-mm fragment of this tumor was
retransplanted into a second animal and formed the upper tumor after 42 days. The two tumors are shown at the same magnification. (B) Hematoxylin and eosin–
stained sections of the primary SV40 LT/Ras tumor (left) and the secondary tumor (center) together with examples of abnormal nuclei and abnormal mitotic
chromosomes in secondary tumors (right). (C) DNA damage foci visualized by colocalization of 53BP1 and c-H2AX. A primary SV40 LT/Ras tumor was fixed and
sectioned as described in the Materials and Methods section, and sections were incubated with antibodies against 53BP1 (visualized with Texas Red) and c-H2AX
(visualized with fluorescein). Sections were also stained with DAPI to show nuclei. (D) Examples of an anaphase bridge and chromatin strings between interphase
nuclei in tumor cells placed in culture (DAPI stain).
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been puzzling, given the central role of oncogenic Ras in in-
creasing proliferation, invasion, angiogenesis, and other fea-
tures of tumors in vivo [2,3]. Ras-induced senescence requires
the activity of p16INK4A [31,35–38]. The passage-dependent
induction of senescence by RasG12V is correlated with an
increase in p16 as a function of PDL [21,31]. This increase in
p16 appears to be a response to oxidative or other forms of
damage incurred during growth in culture [39]. These results
question whether p16-dependent Ras-induced senescence
represents a barrier that must be overcome for cells to respond
to the protumorigenic effects of Ras in a living tissue. It is im-
portant to define sets of genes that are required for neoplastic
transformation using early-passage cells, thereby avoiding ar-
tificial barriers to transformation that have been acquired by
the cells during growth in culture.
Evidently, the microenvironment in the kidney is ideal for
the survival, growth, and vascularization of both normal and
neoplastic cells. The critical features of this microenvironment
have not been definitively identified; important features may
be the proximity to abundant capillaries within the kidney and
the positive interstitial fluid pressure [40]. This site is also
ideal for revealing invasive behavior of tumorigenic cells,
as malignant cells grow between renal tubules, eventually
destroying the entire organ. We confirmed earlier observa-
tions that normal human fibroblasts, as well as fibroblasts
expressing only SV40 LT or only Ras, have no malignant
properties when transplanted in the kidney. They form a thin
layer on top of the kidney parenchyma. A clear boundary with
the kidney is maintained and there is no sign of invasion
(data not shown). A relevant question is whether the kidney
is an ‘‘ectopic’’ site for the growth of neoplastic fibroblasts
and that the subcutaneous site might be more ‘‘physiologi-
cal.’’ However, it should be noted that fibroblasts occur in all
organs of the body and could potentially (although rarely)
form a tumor in any organ. Conversely, subcutaneous injec-
tion actually places the cells beneath the panniculus carno-
sus and not within the dermis; they are therefore not actually
within the skin.
The present experiments lead to the conclusion that both
hTERT and SV40 ST are dispensable for tumorigenic growth
of human fibroblasts. However, both genes are required for
tumorigenic growth of cells beneath the skin, and hTERT is
also required for long-term tumorigenicity of SV40 LT/Ras–
transduced cells. The latter effect of hTERT is specific
for the rescue of cells that have reached crisis. Whereas
SV40 LT/Ras–transduced cells are clearly malignant, as
evidenced by invasive and metastatic growth, which may
result in the death of the animal, they are nevertheless not
immortal. Growth of the tumors eventually ceases because
of telomere shortening, which leads to crisis. Crisis was
demonstrated by nuclear DNA damage foci and mitotic
catastrophe, and by more specific indications of telomere
dysfunction such as anaphase bridges and internuclear
chromatin strings. Cells were rescued from this state by
expression of hTERT, which conferred telomerase activity
and caused telomere lengthening. Under these circum-
stances, hTERT restores the malignant potential of the
cells and permits serial transplantation of the tumor through
multiple host animals. The incidence of DNA damage foci
in tumors was also greatly reduced (data not shown).
Thus, immortalization, as a feature of cancer cells, should
be distinguished from other features of malignant cells. In
Figure 4. Restoration of tumorigenicity by transduction with hTERT. (A) Scheme of experiments: Cells isolated from a primary SV40 LT/Ras tumor are infected with
a retrovirus encoding hTERT; following drug selection, cells are retransplanted into a host animal. The tumor that forms may then be serially transplanted.
(B) Southern blot of restriction enzyme-digested DNA hybridized with a telomere sequence probe. (1) HCA2 cells; (2) SV40 LT/RasG12V– transduced HCA2 cells;
(3) these cells were transplanted and formed a tumor, from which cells were isolated and purified by flow sorting; (4) the tumor cells were transduced with hTERT,
retransplanted to form a tumor, from which cells were isolated and flow-sorted; (5) this tumor was transplanted to another animal and regrew; cells were again
isolated and flow-sorted. (C) Telomerase activity. (0) No sample; (1) HCA2 cells transduced with SV40 LT and RasG12V; (2) these cells were transplanted and
formed a tumor, from which cells were isolated and purified by flow sorting; (3) these tumor cells were transduced with hTERT (50, 100, and 200 ng of protein for
each sample). (D) Tumor formation from SV40 LT/RasG12V– transduced HCA2 cells following isolation of the cells from a primary tumor, transduction with hTERT,
and regrowth in the subrenal capsule assay. Tumor at 38 days (upper left); tumor formed by retransplantation of a 1-mm fragment from this tumor in another animal
at 28 days (upper right); lung metastases in the same animal (lower left); invasion into the kidney of a serially transplanted tumor (lower right).
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order for cells to form a lethal cancer, they must have
acquired the ability to bypass normal controls on cell prolif-
eration, the ability to invade and destroy organs, and the
ability to form distant metastases. Although other properties
of cancer cells are commonly observed, such as resistance
to apoptosis and immortality, there is no a priori reason for
those properties to be essential for cells to form a lethal
cancer. In the SV40 LT/SV40 ST/Ras/hTERT model of neo-
plastic transformation of human fibroblasts, the absolute
requirement for hTERT is problematic. If immortalization is
the specific property conferred by hTERT, then one would
expect that cells with relatively long telomeres should still
be converted to tumor cells by SV40 LT/SV40 ST/Ras and
that such cells would develop a requirement for telomerase
only when telomeres have shortened to a critical extent, as
shown here in the subrenal capsule assay. In contrast, in the
subcutaneous assay, the SV40 LT/SV40 ST/Ras combina-
tion produced no tumors in extensive trials [1,29,41–43].
These data suggest that, in the subcutaneous site,
hTERT has an essential role in tumorigenesis by conferring
properties on cells, other than immortalization. The require-
ment for hTERT may reflect one or more of the many other
reported effects of high-level hTERT expression in cells,
including stimulation of cell proliferation and antiapoptotic
effects [14]. Further studies are needed to define the cellular
and molecular processes/pathways that must be targeted
to permit the survival and growth of cells in the subcutaneous
site, which are not needed in the subrenal capsule site. They
could include resistance to stresses, such as osmotic stress,
lack of nutrients, oxidative stress, and hypoxia. Because these
genetic modifications are not required for tumorigenicity per
se, genes that have been identified in the past as oncogenes
(or classified as nononcogenic) based on subcutaneous
injection experiments need to be restudied using growth of
cells within an internal organ.
In summary, the minimal set of genetic changes required
for tumorigenicity of human fibroblasts was assessed by
implanting cells in immunodeficient host animals at a site
that permits optimal cell survival, using early-passage cells
that have not acquired artefactual barriers to neoplastic
transformation. The cellular pathways targeted by SV40
large T antigen (p53 and pRb) and those targeted by acti-
vated Ras represent a minimal set of genetic alterations
required for the conversion of normal human fibroblasts into
cancer cells.
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